# Ross Marsh Foster Myers & Quiggle — Pipeline Safety Interpretation

**Citation:** PI-91-038  
**Type / status:** guidance / guidance  
**Agency:** Pipeline and Hazardous Materials Safety Administration  
**Effective:** Not stated  
**Published:** 1991-12-26

PI-91-038 response to Ross Marsh Foster Myers & Quiggle concerning 192.1.

## Document text

<<<PAGE 1>>>

Ms. Nancy J. Skancke
Ross Marsh Foster Myers & Quiggle
888 Sixteenth Street N. W.
Washington, DC 20006
Dear Ms. Skancke:
This responds to your letter of August 23, 1991, regarding the drug testing regulations under 49
CFR Part 199. You asked whether personnel at two gas processing plants are subject to drug
testing under those regulations.
According to your letter, two plants are in a rural area outside the areas described by 49 CFR
192.1(b)(2). The plants receive gas from a gas gathering system and process the gas by removing
natural gas liquids (NGLs). The NGLs are pumped into a hazardous liquid pipeline that is subject
to 49 CFR Part 195. The processed gas is then returned to the supplier, who transports it to an
interstate gas pipeline.
You also said that personnel in the plants affect the flow of gas and NGLs in the gas and
hazardous liquid pipelines. They affect flow through their operation and control of the plant
metering stations.
Under Part 199, persons who are subject to drug testing are called "employees." (See §199.11.)
The term "employee" is defined in §199.3 as a person who performs on a pipeline any operating,
maintenance, or emergency-response function that is regulated by 49 CFR Part 192, 193 or 195.
Part 192 does not apply to the gathering of gas that occurs onshore outside the areas listed in
§192.1(b)(2). Such gas gathering extends up to, and includes, gas processing plants. So persons
are not subject to drug testing under Part 199 for work done on facilities used int he processing of
gas inside a gas processing plant that lies onshore outside the areas listed in §192.1(b)(2). Your
letter indicates that persons working in the two plants fall under this exception from Part 199.
Part 195 does not apply to refining or manufacturing facilities or associated in-plant piping
(§195.1(b)(6). this exclusion covers the facilities used in the collection of NGLs inside a gas
processing plant. Thus, persons are not subject to drug testing under Part 199 for work done on
facilities used in the collection of NGLs inside a gas processing plant, regardless of the location of
the plant. Your letter indicates that persons working in the two plants fall under this exception
from Part 199.
DB
C:\WP51\INTERPRT\192\1\91-12-26
1

<<<PAGE 2>>>

Note, however, that Parts 192 and 195 require the operators of the pipelines supplied by the gas
processing plants to control pressure in the pipelines within prescribed limits (§§192.619 and
195.406). So, for transfers of gas or NGL from a gas processing plant to a pipeline regulated by
Part 192 or 195, in-plant piping ends and the regulated pipeline begins at the inlet of each pressure
control device on plant grounds that is necessary for the pipeline operator to control pressure in
the pipeline outside the plant grounds. Sometimes the operator has adequate alternative means to
control pressure in the pipeline outside the plant grounds. In these cases, we consider the in-plant
piping to end and the regulated pipeline to begin at the boundary of the plant grounds, which
usually is marked by a fence.
The operator of a regulated pipeline does not always own the devices located on the grounds of a
gas processing plant (e.g., metering and pumping equipment) that are necessary to control
pipeline pressure outside the grounds. The operator, nonetheless, is responsible for compliance
with the Part 192 or 195 standards applicable to those devices. Compliance is required because
the operator is using or relying on the devices to operate its pipeline within the Part 192 or 195
pressure limitations. In addition, §199.11 requires the pipeline operator to drug test persons who
perform on those devices any operating, maintenance, or emergency response function that Part
192 or Part 195 regulates. Your letter indicates that persons working in the two plants are
subject to the drug testing requirements of §199.11.
Sincerely,
Cesar DeLeon
Director for Pipeline
Safety Regulatory Programs
DB
C:\WP51\INTERPRT\192\1\91-12-26
2

## Provenance

- Official: Yes
- Source: <https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/Pipeline/1991/PI91038.pdf>
- Source ID: `phmsa`
- SHA-256: `5bd2d991d7526708175eac784dbabd65eb77f974cea693160cb63f864b5e7c9d`
- Retrieved: 2026-08-20T00:59:31.977Z
- Exported: 2026-08-22T05:23:45.539Z
- Document slug: `phmsa-interpretation-pi-91-038`

### Source metadata

```json
{
  "materialSubtype": "interpretation",
  "interpretationArea": "pipeline_safety",
  "representation": "full_text_from_official_pdf",
  "companies": [
    "Ross Marsh Foster Myers & Quiggle"
  ],
  "individuals": [
    "Nancy J. Skancke"
  ],
  "refIds": [
    "PI-91-038"
  ],
  "catalogDates": [
    "1991-12-26"
  ],
  "catalogParts": [
    192
  ],
  "catalogRowCount": 1,
  "sourceRecordUrls": [
    "https://www.phmsa.dot.gov/node/57481"
  ],
  "linkedAttachmentUrls": [],
  "unavailableResponseUrls": [],
  "duplicateRepresentationUrls": [],
  "citedSections": [
    "192.1",
    "192.1(b)(2)",
    "199.11",
    "199.3",
    "195.1(b)(6)",
    "192.619",
    "195.406"
  ],
  "catalogPageUrls": [
    "https://www.phmsa.dot.gov/regulations/title49/section/1921"
  ],
  "pdfUrls": [
    "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/Pipeline/1991/PI91038.pdf"
  ],
  "representations": [
    {
      "viewUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/Pipeline/1991/PI91038.pdf",
      "detailUrl": null,
      "detailHtmlPath": null,
      "pdfUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/Pipeline/1991/PI91038.pdf",
      "pdfArtifactPath": "data/sources/phmsa-interpretations/pi-91-038.pdf",
      "pdfArtifactSha256": "a8eb102d152aca898e2c061b8afbc0473527b9fae3141163ba16a5a60bce3ed6",
      "extractedTextPath": "data/sources/phmsa-interpretations/pi-91-038.v2.txt",
      "extractedTextSha256": "b1bef73a154b49e283cf5709677157749a81eda62eba1ff9f7cb7615ea4c0987",
      "pageCount": 2,
      "extractionVersion": 2
    }
  ],
  "caveat": "Interpretations apply regulations to the facts presented and do not create independently enforceable requirements.",
  "jurisdiction": "US"
}
```
